Compare Brevis (BREV) vs Cudis (CUDIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Cudis — how do they compare? Brevis trades at Rp1,315 (market cap Rp330,38M, Rp228,73M 24h volume), while Cudis trades at Rp88.48 (market cap Rp21,97M, Rp86,79M 24h volume). The key difference: Brevis is far larger — about 15× Cudis's market cap, and Brevis's circulating supply is 250M / 1B BREV (25%) versus 247,5M / 1B CUDIS (25%) for Cudis. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 6 Days and Cudis for 11 Days on average.
| BREV | CUDIS | |
|---|---|---|
Market Cap | Rp330,38M | Rp21,97M |
Volume (24h) | Rp228,73M | Rp86,79M |
Circulating Supply | 250M / 1B BREV (25%) | 247,5M / 1B CUDIS (25%) |
Typical Hold Time | 6 Days | 11 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Brevis (BREV) shows mixed technical signals with an overall bullish bias despite bearish moving averages. The token trades at Rp1,345.9 with a market cap of Rp333.86 million and 25% circulating supply. Key technical indicators show RSI_6 at 27.08 (oversold) and strong ADX readings suggesting trending momentum. Support levels are established at Rp1,256-Rp1,335 while resistance sits at Rp1,413-Rp1,492.
Overall outlook suggests cautious optimism with oversold RSI signaling potential rebound. Key opportunities include technical bounce from support levels, while major risks involve limited liquidity (Rp333.86M market cap) and absence of recent protocol updates. Investors should monitor volume confirmation for sustained moves.
Cudis is trading at Rp87.293 with a market cap of Rp21.8M, showing a bearish technical outlook as moving averages signal strong selling pressure and oscillators remain neutral. The asset is near resistance at Rp86 with support at Rp80, while RSI_6 at 13.35 indicates potential oversold conditions. No recent protocol updates or ecosystem developments have been noted, and the token's circulating supply is 247.5M out of a 1B max supply, with a 25% circulation rate.
Overall, the outlook is cautious due to bearish signals and low liquidity, but the oversold RSI may present a short-term opportunity. Major risks include high volatility, limited exchange depth, and regulatory uncertainty in crypto markets. Investors should monitor for any network activity shifts or exchange listings that could impact price dynamics.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Cudis
CUDIS is creating the first-ever Longevity Protocol aimed at making longevity trackable, personalized, and rewarding. By integrating the CUDIS Ring, an AI-powered Longevity Hub, and a blockchain-driven Super App, users will have complete ownership of their health data, receive real-time insights on their longevity, and gain economic incentives for optimizing their biological health. CUDIS is building a new ecosystem for longevity that includes realistic and effective products, programs, and services, in collaboration with partners around the world.
Read more on CUDIS →
